Jiangsu approves two TCM medicines for novel coronavirus pneumonia

Jiangsu Hospital of Traditional Chinese Medicine has completed the registration for two TCM preparations developed to treat patients of COVID-19, the first of its kind in the province, according to Jiangsu Medical Products Administration.

Clinical applications show the two TCM medicines, when combined with western medicines, can improve the treatment, reduce the side effects of western medicine, alleviate symptoms, and shorten patient’s hospital stay.

 

Since the outbreak of the COVID-19, Jiangsu Hospital of Traditional Chinese Medicine has established a team of experts to help the epidemic prevention and control work. The newly developed TCM medicine is a result of extensive researches of fever patients and those under medical observation at the hospital as well as treatment of COVID-19 patients in Jiangsu and Hubei’s temporary hospitals.

Leave a Reply

Your email address will not be published. Required fields are marked *